Hinge Health Statistics
Total Valuation
Hinge Health has a market cap or net worth of $9.84 billion. The enterprise value is $9.52 billion.
| Market Cap | 9.84B |
| Enterprise Value | 9.52B |
Important Dates
The last earnings date was Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hinge Health has 81.27 million shares outstanding. The number of shares has increased by 119.05% in one year.
| Current Share Class | 68.49M |
| Shares Outstanding | 81.27M |
| Shares Change (YoY) | +119.05% |
| Shares Change (QoQ) | +3.72% |
| Owned by Insiders (%) | 16.90% |
| Owned by Institutions (%) | 85.88% |
| Float | 51.20M |
Valuation Ratios
The trailing PE ratio is 60.91 and the forward PE ratio is 41.24. Hinge Health's PEG ratio is 0.41.
| PE Ratio | 60.91 |
| Forward PE | 41.24 |
| PS Ratio | 12.22 |
| Forward PS | 9.27 |
| PB Ratio | 33.02 |
| P/TBV Ratio | 82.90 |
| P/FCF Ratio | 31.27 |
| P/OCF Ratio | 30.30 |
| PEG Ratio | 0.41 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 61.86, with an EV/FCF ratio of 30.25.
| EV / Earnings | 56.94 |
| EV / Sales | 11.82 |
| EV / EBITDA | 61.86 |
| EV / EBIT | 63.04 |
| EV / FCF | 30.25 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.04 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 47.59% and return on invested capital (ROIC) is 387.42%.
| Return on Equity (ROE) | 47.59% |
| Return on Assets (ROA) | 11.42% |
| Return on Invested Capital (ROIC) | 387.42% |
| Return on Capital Employed (ROCE) | 45.59% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $557,286 |
| Profits Per Employee | $115,700 |
| Employee Count | 1,437 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 6.90 |
Taxes
| Income Tax | -2.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +174.43% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +174.43% |
| 50-Day Moving Average | 103.37 |
| 200-Day Moving Average | 70.56 |
| Relative Strength Index (RSI) | 67.02 |
| Average Volume (20 Days) | 2,018,435 |
Short Selling Information
The latest short interest is 6.31 million, so 7.76% of the outstanding shares have been sold short.
| Short Interest | 6.31M |
| Short Previous Month | 4.83M |
| Short % of Shares Out | 7.76% |
| Short % of Float | 12.32% |
| Short Ratio (days to cover) | 3.51 |
Income Statement
In the last 12 months, Hinge Health had revenue of $800.82 million and earned $166.26 million in profits. Earnings per share was $1.99.
| Revenue | 800.82M |
| Gross Profit | 687.05M |
| Operating Income | 150.17M |
| Pretax Income | 166.31M |
| Net Income | 166.26M |
| EBITDA | 153.05M |
| EBIT | 150.17M |
| Earnings Per Share (EPS) | $1.99 |
Balance Sheet
The company has $354.20 million in cash and investments and $33.88 million in debt, with a net cash position of $320.32 million or $3.94 per share.
| Cash & Investments | 354.20M |
| Total Debt | 33.88M |
| Net Cash | 320.32M |
| Net Cash Per Share | $3.94 |
| Equity (Book Value) | 299.42M |
| Book Value Per Share | 3.69 |
| Working Capital | 23.15M |
Cash Flow
In the last 12 months, operating cash flow was $322.99 million and capital expenditures -$10.03 million, giving a free cash flow of $312.97 million.
| Operating Cash Flow | 322.99M |
| Capital Expenditures | -10.03M |
| Depreciation & Amortization | 2.68M |
| Net Borrowing | n/a |
| Free Cash Flow | 312.97M |
| FCF Per Share | $3.85 |
Margins
Gross margin is 85.79%, with operating and profit margins of 18.75% and 21.02%.
| Gross Margin | 85.79% |
| Operating Margin | 18.75% |
| Pretax Margin | 20.77% |
| Profit Margin | 21.02% |
| EBITDA Margin | 19.11% |
| EBIT Margin | 18.75% |
| FCF Margin | 39.08% |
Dividends & Yields
Hinge Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -119.05% |
| Shareholder Yield | -119.05% |
| Earnings Yield | 1.64% |
| FCF Yield | 3.20% |
Analyst Forecast
The average price target for Hinge Health is $135.38, which is 11.78% higher than the current price. The consensus rating is "Buy".
| Price Target | $135.38 |
| Price Target Difference | 11.78% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 32.79% |
| EPS Growth Forecast (3Y) | 18.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hinge Health has an Altman Z-Score of 4.83 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.83 |
| Piotroski F-Score | 5 |